+Search query
-Structure paper
Title | Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration. |
---|---|
Journal, issue, pages | Mol. Immunol., Vol. 165, Page 29-41, Year 2023 |
Publish date | Feb 28, 2023 (structure data deposition date) |
Authors | Jindal, S. / Pedersen, D.V. / Gera, N. / Chandler, J. / Patel, R. / Neill, A. / Cone, J. / Zhang, Y. / Yuan, C.X. / Millman, E.E. ...Jindal, S. / Pedersen, D.V. / Gera, N. / Chandler, J. / Patel, R. / Neill, A. / Cone, J. / Zhang, Y. / Yuan, C.X. / Millman, E.E. / Carlin, D. / Puffer, B. / Sheridan, D. / Andersen, G.R. / Tamburini, P. |
External links | Mol. Immunol. / PubMed:38142486 |
Methods | X-ray diffraction |
Resolution | 1.3 - 4.2 Å |
Structure data | PDB-8coe: PDB-8coh: |
Chemicals | ChemComp-NAG: ChemComp-CIT: ChemComp-MN: ChemComp-HOH: |
Source |
|
Keywords | IMMUNE SYSTEM / innate immunity / complement / terminal pathway / nanobody / antigen-antibody complex |